These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3404694)

  • 1. [Progress in the study of lipoprotein metabolism and atherosclerosis: organ-specific characteristics of lipoprotein metabolic disorders--with special reference to the heart and brain].
    Tamachi H; Goto Y
    Nihon Rinsho; 1988 Mar; 46(3):671-8. PubMed ID: 3404694
    [No Abstract]   [Full Text] [Related]  

  • 2. [The significance of the determination of apoproteins in the diagnosis of lipoprotein metabolism disorders].
    Lepsanović L
    Med Pregl; 1990; 43(1-2):61-8. PubMed ID: 2215396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein metabolism and the role of apolipoproteins as metabolic programmers.
    Dolphin PJ
    Can J Biochem Cell Biol; 1985 Aug; 63(8):850-69. PubMed ID: 3904949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone therapy, lipoprotein subclasses, and coronary calcification: the Healthy Women Study.
    Mackey RH; Kuller LH; Sutton-Tyrrell K; Evans RW; Holubkov R; Matthews KA
    Arch Intern Med; 2005 Mar; 165(5):510-5. PubMed ID: 15767525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein metabolism and atherosclerosis.
    Kent S
    Geriatrics; 1978 Jul; 33(7):93, 96, 99-100. PubMed ID: 208923
    [No Abstract]   [Full Text] [Related]  

  • 6. [The biochemical risk factors of coronary atherosclerosis].
    Titov VN
    Ter Arkh; 1991; 63(4):141-4. PubMed ID: 2068668
    [No Abstract]   [Full Text] [Related]  

  • 7. Atherosclerosis of retinal arteries in men: role of serum lipoproteins and apoproteins.
    Tedeschi-Reiner E; Reiner Z; Sonicki Z
    Croat Med J; 2004 Jun; 45(3):333-7. PubMed ID: 15185429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lipids, lipoproteins, apoproteins and clinical arteriopathic manifestations].
    Rouffy J; Chanu B; Bakir R; Goy-Loeper J; Miro I
    Pathol Biol (Paris); 1983 Apr; 31(4):261-70. PubMed ID: 6346239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The clinical instrumental evaluation of treatment efficacy in patients with concomitant atherosclerosis of the coronary, cerebral and peripheral arteries].
    Karpov RS; Dudko VA; Shipulin VM; Kanskaia NV; Koshel'skaia OA; Stepanian NA; Fedorova NA; Balabanova AV
    Ter Arkh; 1991; 63(4):90-3. PubMed ID: 2068687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of apo-lipoproteins in human carotid artery plaques.
    Hoff HF; Heideman CL; Noon GP; Meyer JS
    Stroke; 1975; 6(5):531-4. PubMed ID: 1179463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Etiopathogenesis of atherosclerosis--a clinical problem that is still relevant].
    Mizerska M; Goch JH
    Pol Merkur Lekarski; 2006 Feb; 20(116):133-8. PubMed ID: 16708625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of plasma lipids in carotid bifurcation atherosclerosis.
    Ford CS; Crouse JR; Howard G; Toole JF; Ball MR; Frye J
    Ann Neurol; 1985 Mar; 17(3):301-3. PubMed ID: 3994317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Disorders in lipoprotein metabolism indices in cerebral atherosclerosis, their importance for diagnosis and medical-occupational expertise].
    Mitsenko MD; Mikhaĭliuk IA; Kukhtevich II
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(7):998-1003. PubMed ID: 197759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome.
    Joven J; Villabona C; Vilella E; Masana L; Albertí R; Vallés M
    N Engl J Med; 1990 Aug; 323(9):579-84. PubMed ID: 2381443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lipoprotein and apoprotein changes in type-2 diabetes mellitus].
    Dobrev D; Terzieva Ts; Krŭstev I; Petrova V; Ivanov I
    Vutr Boles; 1988; 27(5):24-8. PubMed ID: 3213033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Arteriosclerosis indices of lipid and lipoprotein metabolism].
    Reuter W; Herrmann W; Voigt H; Köhler H; Schütz C; Hanf S; Lindhofer HG; Kuklinski B
    Z Arztl Fortbild (Jena); 1984; 78(6):239-41. PubMed ID: 6730538
    [No Abstract]   [Full Text] [Related]  

  • 17. [Analysis of lipoprotein metabolism in alcoholics].
    Mizukami Y; Okazaki M; Usui S; Hosaki S; Maruyama K; Hosokawa Y
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2008 Apr; 43(2):110-9. PubMed ID: 18516950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum levels of lipids, lipoproteins and apoproteins (A, A-1, and B) in diabetes mellitus type I. Their relationship with the degree of metabolic control].
    Barba Chacón A; Mangas-Rojas A; García Rojas JF; Zamora-Madaria E
    An Med Interna; 1990 Apr; 7(4):178-81. PubMed ID: 2103782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The state of fat-lipid metabolism in atherosclerotic parkinsonism in old age (clinico-biochemical parallels)].
    Vaĭnshtok AB; Poliukhov AM; Oleĭnik LI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(6):828-34. PubMed ID: 5471605
    [No Abstract]   [Full Text] [Related]  

  • 20. Atherosclerotic risk factors in cardiovascular disease.
    LaRosa JC
    J Reprod Med; 1986 Sep; 31(9 Suppl):906-12. PubMed ID: 3772910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.